|
|
|
4592 SanBio Company Limited
|
|
| 10/30/2026 15:30 |
Notice Regarding Conclusion of a Committed Credit Line Agreement with Resona Bank, Limited and Expansion of Borrowing Facility |
| 10/07/2026 15:30 |
[Delayed]Notice Regarding the First Post-Marketing Administration of AKUUGO(R) Suspension for Intracranial Implantation |
| 09/17/2026 15:30 |
Presentation for Financial Results for the 2nd Quarter of the Fiscal Year Ending January 31, 2027 |
| 09/15/2026 15:30 |
[Delayed] Consolidated Financial Results for the Six Months Ended July 31, 2026 [Japanese GAAP] |
| 09/15/2026 15:30 |
[Delayed]Notice Concerning Differences between the Consolidated Earnings Forecast and Actual Results for 2Q of the Fiscal Year Ending January 31, 2027 |
| 09/14/2026 15:30 |
Notice Concerning Recording of Non-operating Income,Non-operating Expenses and Deferred Income Taxes |
| 06/16/2026 15:30 |
[Delayed]Notice Concerning Recording of Non-operating Income and Deferred Income Taxes |
| 06/15/2026 15:30 |
Consolidated Financial Results for the Three Months Ended April 30, 2026[Japanese GAAP] |
| 06/01/2026 15:30 |
[Delayed]Notice Regarding the Launch of AKUUGO(R), a New Treatment Option for Chronic Motor Paralysis Following Traumatic Brain Injury |
| 05/25/2026 18:00 |
[Delayed]Notice Regarding NHI Price Listing of AKUUGO(R) Suspension for Intracranial Implantation |
| 05/19/2026 15:30 |
[Delayed]Notice Concerning Chuikyo Approval of Proposed NHI Price for AKUUGO(R) and Revision of Consolidated Earnings Forecast for FY Ending Jan. 2027 |
| 03/25/2026 15:30 |
Presentation for Financial Results for the Fiscal Year Ending January 31, 2026 |
| 03/17/2026 15:30 |
Announcement on Reduction in Amounts of Stated Capital and Capital Reserves and Appropriation of Other Capital Surplus |
| 03/17/2026 15:30 |
Notice Concerning Recording of Non-operating Expenses and Deferred Income Taxes |
| 03/17/2026 15:30 |
Consolidated Financial Results for the Fiscal Year Ended January 31, 2026 [Japanese GAAP] |
| 01/27/2026 16:30 |
Determination of Terms and Conditions of Stock Options(Share Acquisition Rights) |
| 01/09/2026 15:30 |
Announcement on Granting Stock Options (Share Acquisition Rights) |
| 12/15/2025 15:30 |
Consolidated Financial Results for the Nine Months Ended October 31, 2025 [Japanese GAAP] |
| 12/15/2025 15:30 |
Notice Concerning Recording of Non-operating Expenses and Deferred Income Taxes |
| 12/08/2025 15:30 |
Appointment of Two Corporate Officers in the Quality Compliance & Regulatory Affairs Division and the Production Division |
| 11/06/2025 23:30 |
Announcement of Determination of Issue Price and Other Matters for Issuance of New Shares Through an International Offering |
| 11/06/2025 16:00 |
Announcement of Issuance of New Shares Through an International Offering |
|
